MannKind

Created with Highcharts 10.1.0Chart context menu


Ebit Zmiana Data
Adma Biologics USD 39.64M 437K 2024-09
Dynavax Technologies USD -1632000 11.71M 2024-12
Eli Lilly USD 5.63B 3.88B 2024-12
Halozyme Therapeutics USD 182.75M 19.56M 2024-12
Insmed USD -245214000 31.78M 2024-12
MacroGenics USD 54.52M 112.7M 2024-09
MannKind USD 26.49M 13.74M 2024-12
Merck USD 5.22B 339M 2024-12
Novo Nordisk DKK 33.82B 6.93B 2024-09
Pfizer USD 4.62B 2.42B 2024-12
Sanofi EUR 2.08B 1.69B 2024-12
Xencor USD -13178000 47.7M 2024-12



MannKind - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.